MarketPeel
Insider Trading Intelligence
Pricing
…
ML

Mark N. Lampert

CYTK
10% OWNER · CYTOKINETICS INC · CIK 0001233840
FILING MIX · LIFETIME76%/24%
BUYS
268
SELLS
83
TOTAL VALUE
$790.70M
COMPANIES
13
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
16,936,759
AVG SELL PX
$39.04
TRADE KIND
SHOWING 351 / 351
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
164 backtested trades · 8 horizons · 26 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mark N. Lampert, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d164+61.59%+1.75%+0.03%+1.72%+0.36%2.18
14d164+64.02%+2.46%+0.27%+2.19%+1.25%2.19
30d164+56.71%+2.28%+0.76%+1.53%+0.91%0.98
60d164+68.90%+12.29%+3.03%+9.49%+6.10%3.65
90d164+67.07%+26.84%+4.81%+22.03%+4.20%5.57
180d164(3 pending)+64.60%+28.92%+8.63%+20.29%+9.56%4.47
1y164(3 pending)+57.76%+30.72%+20.31%+10.41%+1.16%2.14
2y164(20 pending)+63.19%+53.36%+33.71%+19.65%-18.27%2.75
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CYTK · 2,760,185 shares · as of Dec 9, 2020
0952,8181,905,6362,858,4533,811,271SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 268 buys / 83 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KYMR
KYMERA THERAPEUTICS, INC.
SALE
113,289$106.50$12.07M240,123Jun 26, 2026Jun 26, 2026 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
51,858$106.50$5.52M78,787Jun 26, 2026Jun 26, 2026 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
837,914$106.50$89.24M1,960,881Jun 26, 2026Jun 26, 2026 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
627,597$106.50$66.84M1,592,261Jun 26, 2026Jun 26, 2026 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,068——6,068Jun 24, 2026Jun 25, 2026 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
29,500——29,500Jun 18, 2026Jun 23, 2026 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASEGRANT
Stock grant
22,195——22,195Jun 17, 2026Jun 22, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,506,000$4.03$6.07M2,773,545May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
772——0May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
1,506——0May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
412——0May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
2,313,000$4.03$9.32M3,635,758May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
412,000$4.03$1.66M412,000May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
772,000$4.03$3.11M772,000May 14, 2026May 18, 2026 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
2,313——0May 14, 2026May 18, 2026 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
248,530$16.79$4.17M1,039,238Mar 31, 2026Apr 2, 2026 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
1,569,116$16.79$26.35M6,599,722Mar 31, 2026Apr 2, 2026 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
1,932,354$16.79$32.44M8,302,735Mar 31, 2026Apr 2, 2026 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
142,604$44.00$6.27M2,798,795Jun 30, 2025Jul 1, 2025 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
58,780$44.00$2.59M353,412Jun 30, 2025Jul 1, 2025 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
115,783$44.00$5.09M2,219,858Jun 30, 2025Jul 1, 2025 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,000——16,000Jun 25, 2025Jul 1, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASE
56,079——62,383Jun 13, 2025Jun 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASE
257,515——257,515Jun 13, 2025Jun 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASE
304,098——304,098Jun 13, 2025Jun 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASE
556,617——593,740Jun 13, 2025Jun 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASE
657,308——707,116Jun 13, 2025Jun 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASE
25,944——25,944Jun 13, 2025Jun 17, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,150——24,150Jun 11, 2025Jun 13, 2025 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASEGRANT
Stock grant
6,682——6,682Jun 5, 2025Jun 9, 2025 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
127,407$27.10$3.45M1,322,758May 16, 2025May 20, 2025 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
265,316$27.10$7.19M1,267,545May 16, 2025May 20, 2025 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
149,975$26.10$3.91M0Jan 24, 2025Jan 28, 2025 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
339,679$26.10$8.87M1,450,165Jan 24, 2025Jan 28, 2025 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
85,776$26.10$2.24M1,532,861Jan 24, 2025Jan 28, 2025 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
75,287$26.10$1.96M0Jan 24, 2025Jan 28, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
235,450——3,291,004Jan 10, 2025Jan 14, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,740——336,288Jan 10, 2025Jan 14, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
161,810——2,627,590Jan 10, 2025Jan 14, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
22,740——347,970Jan 10, 2025Jan 14, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
161,810——2,003,966Jan 10, 2025Jan 14, 2025 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
235,450——2,655,977Jan 10, 2025Jan 14, 2025 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
234,323——371,916Dec 13, 2024Dec 17, 2024 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
174,958——282,223Dec 13, 2024Dec 17, 2024 ↗View →
PVLA
PALVELLA THERAPEUTICS, INC.
PURCHASE
29,648——38,961Dec 13, 2024Dec 17, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
160,107$9.08$1.45M313,548Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
153,441——370,710Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,797,527——1,797,527Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,047,044$9.08$9.51M2,465,780Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
1,418,736——2,165,776Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,418,736——1,418,736Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
1,797,527——2,891,427Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,258,027$9.08$11.42M3,055,554Dec 4, 2024Dec 4, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
153,441——153,441Dec 4, 2024Dec 4, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
240,000——87,911Nov 8, 2024Nov 13, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
3,062,000——830,237Nov 8, 2024Nov 13, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
3,062,000——3,062,000Nov 8, 2024Nov 13, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
2,378,000——2,378,000Nov 8, 2024Nov 13, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
240,000——240,000Nov 8, 2024Nov 13, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
2,378,000——662,970Nov 8, 2024Nov 13, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
440,489$3.65$1.61M838,507Oct 29, 2024Oct 31, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
2,213,816$3.65$8.08M7,415,596Oct 29, 2024Oct 31, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
2,100,244$3.65$7.66M6,235,545Oct 29, 2024Oct 31, 2024 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
1,030,589$50.00$51.53M10,235,089Oct 4, 2024Oct 8, 2024 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
836,862$50.00$41.84M8,168,838Oct 4, 2024Oct 8, 2024 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
SALE
132,549$50.00$6.63M1,287,768Oct 4, 2024Oct 8, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
156,742$40.75$6.39M156,742Aug 20, 2024Aug 22, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
201,546$40.75$8.21M201,546Aug 20, 2024Aug 22, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,000——16,000Jun 18, 2024Jun 28, 2024 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
23,000——23,000Jun 14, 2024Jun 18, 2024 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASEGRANT
Stock grant
7,688——7,688Jun 6, 2024Jun 10, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
1,031,385——3,361,803May 9, 2024May 13, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
75,431——220,460May 9, 2024May 13, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
2,526,238——2,526,238May 9, 2024May 13, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
232,068——232,068May 9, 2024May 13, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
3,173,135——3,173,135May 9, 2024May 13, 2024 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
821,121——2,633,679May 9, 2024May 13, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
35,000——0Jan 26, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
20,000——0Jan 26, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
341,547——0Jan 25, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
2,076,085——0Jan 25, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
1,367,838——0Jan 25, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
2,870,985——0Jan 25, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
1,734,960——0Jan 25, 2024Jan 29, 2024 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
185,388——0Jan 25, 2024Jan 29, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
550,425$25.25$13.90M550,425Jan 5, 2024Jan 9, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
52,733$25.25$1.33M52,733Jan 5, 2024Jan 9, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
375,856$25.25$9.49M375,856Jan 5, 2024Jan 9, 2024 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
103,885$14.07$1.46M2,656,191Nov 3, 2023Nov 6, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
83,708$14.07$1.18M2,104,075Nov 3, 2023Nov 6, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
10,106$14.07$142.2K294,632Nov 3, 2023Nov 6, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
26,772$11.64$311.7K284,526Nov 2, 2023Nov 6, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
132,016$11.64$1.54M2,020,367Nov 2, 2023Nov 6, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
57,618$11.64$670.9K2,552,306Nov 2, 2023Nov 6, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
99,556——99,556Sep 14, 2023Sep 14, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
775,278$9.84$7.63M4,688,954Sep 12, 2023Sep 14, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
52,801$9.84$519.6K524,151Sep 12, 2023Sep 14, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
677,853$9.84$6.67M3,584,512Sep 12, 2023Sep 14, 2023 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
21,520——21,520Jun 16, 2023Jun 21, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Jun 15, 2023Jun 20, 2023 ↗View →
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
PURCHASEGRANT
Stock grant
11,297——11,297Jun 8, 2023Jun 12, 2023 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASEGRANT
Stock grant
10,967——10,967May 17, 2023May 19, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
SALE
4,018,253——0May 10, 2023May 12, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
SALE
2,929,660——0May 10, 2023May 12, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
SALE
462,605——0May 10, 2023May 12, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
PURCHASE
4,018,253——4,018,253May 10, 2023May 12, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
PURCHASE
462,605——462,605May 10, 2023May 12, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
PURCHASE
2,929,660——2,929,660May 10, 2023May 12, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
1,609,063——1,609,063May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
252,291——252,291May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
2,446,209——2,446,209May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
2,028,645——2,028,645May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
837,146——1,812,558May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
86,341——145,029May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
3,084,090——3,084,090May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
165,950——165,950May 5, 2023May 9, 2023 ↗View →
ELDN
ELEDON PHARMACEUTICALS, INC.
PURCHASE
1,055,445——2,330,418May 5, 2023May 9, 2023 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
2,600,000——392,808Jan 19, 2023Jan 19, 2023 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
350,000——350,000Jan 19, 2023Jan 19, 2023 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
3,500,000——558,854Jan 19, 2023Jan 19, 2023 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
300,000——64,161Jan 19, 2023Jan 19, 2023 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
260,000——260,000Jan 19, 2023Jan 19, 2023 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
30,000——30,000Jan 19, 2023Jan 19, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
15,912$31.24$497.1K1,888,351Jan 12, 2023Jan 13, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
2,985$31.24$93.3K2,494,688Jan 12, 2023Jan 13, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
10,961$29.89$327.6K2,491,703Jan 11, 2023Jan 13, 2023 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
11,149$29.89$333.2K1,872,439Jan 11, 2023Jan 13, 2023 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,573$21.98$34.6K1,618,637Jan 6, 2023Jan 9, 2023 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,676$21.98$36.8K1,789,844Jan 6, 2023Jan 9, 2023 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,330$18.39$61.2K1,788,168Jan 5, 2023Jan 9, 2023 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
15,670$18.39$288.1K1,617,064Jan 5, 2023Jan 9, 2023 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
685,330$5.83$4.00M2,076,085Nov 8, 2022Nov 10, 2022 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
54,857$5.83$319.8K341,547Nov 8, 2022Nov 10, 2022 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
970,171$5.83$5.66M2,870,985Nov 8, 2022Nov 10, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,004$16.89$17.0K1,784,838Sep 27, 2022Sep 27, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
678$16.89$11.5K1,601,394Sep 27, 2022Sep 27, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,339$16.83$56.2K1,783,834Sep 26, 2022Sep 27, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,021$16.83$50.8K1,600,716Sep 26, 2022Sep 27, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
9,885$16.50$163.1K1,597,695Sep 23, 2022Sep 27, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
6,715$16.50$110.8K1,780,495Sep 23, 2022Sep 27, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
13,396$17.89$239.6K1,773,780Sep 16, 2022Sep 16, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
10,897$17.89$194.9K1,587,810Sep 16, 2022Sep 16, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
5,575$17.96$100.1K1,576,913Sep 15, 2022Sep 16, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
26,441$17.25$456.0K1,571,338Sep 14, 2022Sep 16, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
233,362$26.00$6.07M1,861,290Aug 22, 2022Aug 23, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
285,046$26.00$7.41M2,480,742Aug 22, 2022Aug 23, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
27,117$26.00$705.0K257,754Aug 22, 2022Aug 23, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Jun 15, 2022Jun 17, 2022 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
158,583$4.03$639.8K3,913,676Jun 10, 2022Jun 14, 2022 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
41,417$4.03$167.1K2,906,659Jun 10, 2022Jun 14, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
301,009$11.00$3.31M2,992,808Jun 1, 2022Jun 3, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
44,746$11.00$492.2K364,161Jun 1, 2022Jun 3, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
405,641$11.00$4.46M4,058,854Jun 1, 2022Jun 3, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
35,793$14.78$529.1K2,195,696May 27, 2022May 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
26,353$14.78$389.6K1,627,928May 27, 2022May 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
3,223$14.78$47.6K230,637May 27, 2022May 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
10,642$14.21$151.2K227,414May 26, 2022May 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
123,043$14.21$1.75M2,159,903May 26, 2022May 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
90,372$14.21$1.28M1,601,575May 26, 2022May 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
4,180$14.00$58.5K1,511,203May 20, 2022May 24, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
37$14.00$518216,772May 20, 2022May 24, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
5,883$14.00$82.4K2,036,860May 20, 2022May 24, 2022 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASEGRANT
Stock grant
8,996——8,996May 18, 2022May 20, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
38,558$9.14$352.2K2,691,799May 13, 2022May 16, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
53,598$9.14$489.6K3,653,213May 13, 2022May 16, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
17,744$9.14$162.1K319,415May 13, 2022May 16, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
542,999$9.06$4.92M3,599,615May 12, 2022May 16, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
457,001$9.06$4.14M2,653,241May 12, 2022May 16, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
55,210$19.26$1.06M2,030,977May 6, 2022May 9, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
4,131$19.26$79.5K216,735May 6, 2022May 9, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
40,659$19.26$782.9K1,507,023May 6, 2022May 9, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
4,066$19.60$79.7K212,604May 5, 2022May 9, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
70,439$19.60$1.38M1,466,364May 5, 2022May 9, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
75,495$19.60$1.48M1,975,767May 5, 2022May 9, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
266,598$10.75$2.87M3,056,616Apr 1, 2022Apr 5, 2022 ↗View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
9,402$10.75$101.1K2,196,240Apr 1, 2022Apr 5, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
14,323$40.70$582.9K1,395,925Jan 31, 2022Jan 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
20,085$40.70$817.5K1,900,272Jan 31, 2022Jan 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
58,042$38.33$2.22M1,880,187Jan 27, 2022Jan 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
37,859$38.33$1.45M1,381,602Jan 27, 2022Jan 31, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
114,726$37.76$4.33M1,343,743Jan 24, 2022Jan 26, 2022 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
158,041$37.76$5.97M1,822,145Jan 24, 2022Jan 26, 2022 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
14,806$12.00$177.7K185,388Jan 7, 2022Jan 10, 2022 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
255,500$12.00$3.07M1,734,960Jan 7, 2022Jan 10, 2022 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
226,079$12.00$2.71M1,367,838Jan 7, 2022Jan 10, 2022 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
61,343$12.00$736.0K1,141,759Jan 6, 2022Jan 10, 2022 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
362,430$9.39$3.40M3,755,093Nov 30, 2021Dec 2, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
35,268$9.39$331.2K471,350Nov 30, 2021Dec 2, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
341,977$9.39$3.21M2,865,242Nov 30, 2021Dec 2, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
590$13.94$8.2K170,582Sep 21, 2021Sep 23, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
6,341$13.94$88.4K1,479,460Sep 21, 2021Sep 23, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
4,102$13.94$57.2K1,080,416Sep 21, 2021Sep 23, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
158,511$16.49$2.61M1,076,314Sep 13, 2021Sep 15, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
20,512$16.49$338.2K169,992Sep 13, 2021Sep 15, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
213,246$16.49$3.52M1,473,119Sep 13, 2021Sep 15, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
16,980$15.25$258.9K149,480Jul 6, 2021Jul 6, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
146,116$15.25$2.23M1,259,873Jul 6, 2021Jul 6, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
106,627$15.25$1.63M917,803Jul 6, 2021Jul 6, 2021 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
27,458$47.00$1.29M208,538Jul 1, 2021Jul 6, 2021 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
304,997$47.00$14.33M1,664,104Jul 1, 2021Jul 6, 2021 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
211,711$47.00$9.95M1,229,017Jul 1, 2021Jul 6, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
172,457$15.65$2.70M1,113,757Jul 1, 2021Jul 6, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
124,804$15.65$1.95M811,176Jul 1, 2021Jul 6, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
20,018$15.65$313.3K132,500Jul 1, 2021Jul 6, 2021 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,063——20,063Jun 16, 2021Jun 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
129$15.90$2.1K112,482May 24, 2021May 25, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
719$15.90$11.4K941,300May 24, 2021May 25, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
513$15.90$8.2K686,372May 24, 2021May 25, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
7,592$15.94$121.0K112,353May 21, 2021May 25, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
66,242$15.94$1.06M940,581May 21, 2021May 25, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
48,152$15.94$767.6K685,859May 21, 2021May 25, 2021 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASEGRANT
Stock grant
5,101——5,101May 19, 2021May 21, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
1,115$15.88$17.7K104,761May 19, 2021May 20, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
9,191$15.88$146.0K874,339May 19, 2021May 20, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
6,962$15.88$110.6K637,707May 19, 2021May 20, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
75,640$16.65$1.26M630,745May 18, 2021May 20, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
11,946$16.65$198.9K103,646May 18, 2021May 20, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
103,611$16.65$1.73M865,148May 18, 2021May 20, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
31,805$14.26$453.6K761,537May 13, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
22,721$14.26$324.0K555,105May 13, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
3,474$14.26$49.5K91,700May 13, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
10,876$14.90$162.1K532,384Apr 26, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
14,790$14.90$220.4K729,732Apr 26, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
1,747$14.90$26.0K88,226Apr 26, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
14,790$14.90$220.4K729,732Apr 26, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
1,747$14.90$26.0K88,226Apr 26, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
10,876$14.90$162.1K532,384Apr 26, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
134,515——286,691Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
84,350——84,350Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
115,293——115,293Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
53,303$15.93$849.0K714,942Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
152,176——152,176Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
1,068,554——1,900,815Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
115,293——832,261Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
398,300$17.00$6.77M482,650Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
84,350——553,359Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
546,346$17.00$9.29M661,639Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
17,390——17,390Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
832,261——0Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
832,261——832,261Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
134,515——0Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
6,141$15.93$97.8K86,479Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
1,068,554——0Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
553,359——553,359Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
152,176——0Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
837,397——0Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
837,397——1,390,756Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
38,858$15.93$618.9K521,508Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
17,390——152,176Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASEGRANT
Stock grant
62,948$17.00$1.07M80,338Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
SALE
553,359——0Apr 23, 2021Apr 27, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
398,300$17.00$6.77M482,650Apr 23, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
53,303$15.93$849.0K714,942Apr 23, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
6,141$15.93$97.8K86,479Apr 23, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
62,948$17.00$1.07M80,338Apr 23, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
38,858$15.93$618.9K521,508Apr 23, 2021May 17, 2021 ↗View →
RAIN
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
PURCHASE
546,346$17.00$9.29M661,639Apr 23, 2021May 17, 2021 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
84,250$38.36$3.23M75,287Mar 31, 2021Apr 2, 2021 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
279,740$38.36$10.73M1,760,384Mar 31, 2021Apr 2, 2021 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
81,903$38.36$3.14M149,975Mar 31, 2021Apr 2, 2021 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
205,807$38.36$7.89M1,544,897Mar 31, 2021Apr 2, 2021 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
99,556——99,556Mar 31, 2021May 26, 2021 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
4,325$18.00$77.8K233,150Feb 2, 2021Feb 4, 2021 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
25,234$18.00$454.2K1,642,186Feb 2, 2021Feb 4, 2021 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
16,850$18.00$303.3K1,188,131Feb 2, 2021Feb 4, 2021 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
200,000$25.00$5.00M200,000Dec 11, 2020Dec 15, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
239,274$18.00$4.31M3,811,271Dec 9, 2020Dec 11, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
25,486$18.00$458.7K463,244Dec 9, 2020Dec 11, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
166,194$18.00$2.99M2,760,185Dec 9, 2020Dec 11, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
93——0Nov 20, 2020Nov 20, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
551——0Nov 20, 2020Nov 20, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
740——0Nov 20, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
185,908——185,908Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
73,399——361,091Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
101,784——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
613,918$19.00$11.66M3,392,663Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
185,908——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
522,403——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
1,129,404——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
889,186——2,018,590Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
1,129,404——1,129,404Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
760,155——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
522,403——2,076,840Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
881,156——881,156Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
881,156——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
673,281——1,554,437Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
74,991$19.00$1.42M436,082Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
73,399——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
673,281——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
760,155——2,778,745Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
446,425$19.00$8.48M2,523,265Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
889,186——0Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
101,784——287,692Nov 19, 2020Nov 20, 2020 ↗View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
21,520——21,520Nov 18, 2020Nov 20, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
7,201$18.20$131.1K1,750,704Sep 23, 2020Sep 23, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
9,888$18.20$180.0K2,040,124Sep 23, 2020Sep 23, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
6,960$18.45$128.4K2,030,236Sep 22, 2020Sep 23, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
4,991$18.45$92.1K1,743,503Sep 22, 2020Sep 23, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
12,259$18.39$225.4K2,023,276Sep 21, 2020Sep 23, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
10,069$18.39$185.1K1,738,512Sep 21, 2020Sep 23, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,907$18.77$73.3K2,011,017Sep 4, 2020Sep 10, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,830$18.77$71.9K1,728,443Sep 4, 2020Sep 10, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
9,900$18.87$186.8K2,007,110Sep 1, 2020Sep 1, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
7,672$18.87$144.7K1,724,613Sep 1, 2020Sep 1, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
6,862$18.48$126.8K1,716,941Aug 31, 2020Sep 1, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
9,143$18.48$169.0K1,997,210Aug 31, 2020Sep 1, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,122$19.17$21.5K1,988,067Aug 28, 2020Sep 1, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
922$19.17$17.7K1,710,079Aug 28, 2020Sep 1, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
2,244$19.75$44.3K1,709,157Aug 25, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,443$19.75$68.0K1,986,945Aug 25, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
6,504$19.31$125.6K1,983,502Aug 24, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
5,179$19.31$100.0K1,706,913Aug 24, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
9,198$19.32$177.7K1,976,998Aug 21, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,607$19.32$31.0K1,701,734Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
67,791$20.00$1.36M181,081Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
389,709$20.00$7.79M1,017,307Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
1,000,955——0Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
837,916——837,916Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
521,193$20.00$10.42M1,359,109Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
1,336,390——0Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
627,598——627,598Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
113,290——113,290Aug 21, 2020Aug 25, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
180,686——0Aug 21, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,772$19.12$33.9K1,967,800Aug 20, 2020Aug 20, 2020 ↗View →
KYMR
KYMERA THERAPEUTICS, INC.
SALEGRANT
Stock grant
40,127——40,127Aug 20, 2020Aug 25, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
3,496$19.70$68.9K1,966,028Aug 19, 2020Aug 20, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
895$19.27$17.2K1,962,532Aug 18, 2020Aug 20, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
21,922$18.69$409.8K1,961,637Aug 14, 2020Aug 14, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
1,050$17.80$18.7K1,939,715Aug 13, 2020Aug 14, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
4,050$17.34$70.2K1,938,665Aug 12, 2020Aug 14, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
929$13.32$12.4K1,204,981Jun 30, 2020Jul 2, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
81$13.32$1.1K237,475Jun 30, 2020Jul 2, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
1,521$13.32$20.3K1,667,420Jun 30, 2020Jul 2, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
1,354$13.93$18.9K237,394Jun 22, 2020Jun 22, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
10,524$13.93$146.6K1,665,899Jun 22, 2020Jun 22, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
7,854$13.93$109.4K1,204,052Jun 22, 2020Jun 22, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
6,769$14.39$97.4K236,040Jun 19, 2020Jun 22, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
52,443$14.39$754.6K1,655,375Jun 19, 2020Jun 22, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
39,052$14.39$561.9K1,196,198Jun 19, 2020Jun 22, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
596,813$13.00$7.76M1,700,127Apr 15, 2020Apr 17, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
655.959——0Apr 15, 2020Apr 17, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
SALE
596.813——0Apr 15, 2020Apr 17, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
655,959$13.00$8.53M1,934,615Apr 15, 2020Apr 17, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
8,264$17.20$142.1K1,278,656Mar 25, 2020Mar 27, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
4,439$14.52$64.5K1,270,392Mar 18, 2020Mar 20, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
8,113$15.73$127.6K1,265,953Mar 17, 2020Mar 17, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
10,164$15.73$159.9K1,257,840Mar 16, 2020Mar 17, 2020 ↗View →
XOMA
XOMA ROYALTY CORP
PURCHASE
100,000$18.34$1.83M1,247,676Mar 13, 2020Mar 17, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
510,793$15.79$8.06M2,350,829Feb 13, 2020Feb 18, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
74,893$15.79$1.18M424,419Feb 13, 2020Feb 18, 2020 ↗View →
CYTK
CYTOKINETICS INC
SALE
486,344$15.79$7.68M3,131,432Feb 13, 2020Feb 18, 2020 ↗View →
Other insiders · CYTK
Loading peer insiders…
About this filer
CIK 0001233840
ROLE
10% Owner
PRIMARY
CYTK
COMPANIES
13
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001233840DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback